Global Ganja Report

The percentage of military veterans facing challenges from PTSD is staggering, but the Department of Veterans Affairs remains intransigent on allowing access to cannabis—the only treatment that provides relief for many. And there has been little progress on efforts in Congress to remedy the situation.

Building on longstanding policy that bars federal cannabis enforcement in medical marijuana states, the House of Representatives passed a measure that would instate a similar hands-off approach to enforcement in states that have generally legalized. Other measures would slash funding for the DEA, and call upon the FDA to promulgate regs for CBD.

The Cannabis Cultural Association won at least a limited legal victory, with a federal appeals court ruling that the DEA must consider with "alacrity" their petition to have cannabis rescheduled.

Insurance companies in Canada are starting to cover medical marijuana, but high costs continue to be an impediment to access in the United States. Even in states that have legalized medicinal use of cannabis, the insurance industry will provide no coverage. Advocates are now starting to demand legislation to address this contradiction.

Notorious narco-lord "Chapo" Guzmán was convicted by a federal jury in New York and faces life in prison. But violence in Mexico has only escalated since his capture. Few media accounts have noted how Chapo and his Sinaloa Cartel rose as militarized narcotics enforcement escalated in Mexico—a trajectory mirrored by the cartels' move from dealing in cannabis to deadly white powders.

The World Health Organization has released its long-anticipated recommendation on cannabis scheduling. But rather than removing it from Schedule I of the Single Convention, it only removes it from Schedule IV, where it is also listed. CBD, however, has indeed been de-scheduled entirely.

A contraband cannabis economy booms in the Balkan Peninsula, where the wars of the 1990s spurred an underground dope-for-guns network that still thrives today. But amid EU pressure to crack down, a legal industry is now starting to emerge.

When the United Kingdom announced the historic step of rescheduling cannabis and allowing physicians to prescribe it two months ago, there was concern from patients and advocates as to whether actual herbaceous flower would be allowed, or only extracts. Now the first patient is approved to receive cannabis under the program, and it is indeed to be dried flower. The bad news: with the National Health Service barred by bureaucratic hurdles from providing it, patients are at the mercy of the market—and the price is prohibitive.